Stryker Corp (SYK)
327.45
-8.58
(-2.55%)
USD |
NYSE |
Apr 18, 16:00
327.45
0.00 (0.00%)
After-Hours: 20:00
Stryker Enterprise Value: 134.46B for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 134.46B |
| April 17, 2024 | 137.72B |
| April 16, 2024 | 138.34B |
| April 15, 2024 | 138.90B |
| April 12, 2024 | 140.01B |
| April 11, 2024 | 141.62B |
| April 10, 2024 | 142.02B |
| April 09, 2024 | 143.38B |
| April 08, 2024 | 142.94B |
| April 05, 2024 | 143.42B |
| April 04, 2024 | 142.04B |
| April 03, 2024 | 143.41B |
| April 02, 2024 | 142.80B |
| April 01, 2024 | 144.81B |
| March 28, 2024 | 146.03B |
| March 27, 2024 | 146.35B |
| March 26, 2024 | 143.18B |
| March 25, 2024 | 143.43B |
| March 22, 2024 | 144.03B |
| March 21, 2024 | 144.37B |
| March 20, 2024 | 144.25B |
| March 19, 2024 | 145.65B |
| March 18, 2024 | 144.59B |
| March 15, 2024 | 143.88B |
| March 14, 2024 | 145.18B |
| Date | Value |
|---|---|
| March 13, 2024 | 145.65B |
| March 12, 2024 | 146.22B |
| March 11, 2024 | 145.16B |
| March 08, 2024 | 146.03B |
| March 07, 2024 | 145.93B |
| March 06, 2024 | 144.94B |
| March 05, 2024 | 143.94B |
| March 04, 2024 | 145.26B |
| March 01, 2024 | 144.26B |
| February 29, 2024 | 142.68B |
| February 28, 2024 | 143.72B |
| February 27, 2024 | 143.87B |
| February 26, 2024 | 143.97B |
| February 23, 2024 | 144.95B |
| February 22, 2024 | 144.23B |
| February 21, 2024 | 142.11B |
| February 20, 2024 | 142.30B |
| February 16, 2024 | 142.77B |
| February 15, 2024 | 142.57B |
| February 14, 2024 | 142.81B |
| February 13, 2024 | 139.16B |
| February 12, 2024 | 139.65B |
| February 09, 2024 | 139.98B |
| February 08, 2024 | 138.86B |
| February 07, 2024 | 140.27B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
54.08B
Minimum
Mar 23 2020
146.35B
Maximum
Mar 27 2024
101.07B
Average
102.44B
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 107.39B |
| Haemonetics Corp | 4.915B |
| Abbott Laboratories | 190.29B |
| Zimmer Biomet Holdings Inc | 29.98B |
| Edwards Lifesciences Corp | 51.00B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.143B |
| Revenue (Quarterly) | 5.815B |
| Total Expenses (Quarterly) | 4.552B |
| EPS Diluted (Quarterly) | 2.98 |
| Gross Profit Margin (Quarterly) | 63.68% |
| Profit Margin (Quarterly) | 19.66% |
| Earnings Yield | 2.52% |
| Operating Earnings Yield | 3.11% |
| Normalized Earnings Yield | 2.532 |